Viewing nowGlimepizide Tablet 4mg (Gliclazide)
Glimepiride 4mg
Tablet · Prescription medication
Celix Co., Ltd.

MFDS item code 201404009 · Approved 2014.08.28 · Insurance code 646203650
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It acts as an adjunct to dietary and exercise therapy, and is administered alone or in combination with other hypoglycemic agents in cases where blood sugar control is inadequate. It is particularly used when sulfonylurea medications or monotherapy with metformin are not effective, to further enhance blood sugar control. It also aids in blood sugar management when used in conjunction with insulin. This medication improves blood sugar control by being used either alone or in combination therapy tailored to the individual’s condition.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, initiate treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was initially managed successfully. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, the addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.
This medication is not to be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Additionally, it is safer not to administer this medication or its ingredients to patients with known allergies or severely impaired liver or kidney function. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections or those undergoing surgery, or those in severe trauma situations are advised to avoid this medication because insulin therapy is recommended. Patients with gastrointestinal disorders should be cautious due to the risk of hypoglycemia from impaired food absorption. This medication contains lactose and should not be given to patients with lactose intolerance or specific genetic metabolic disorders. During the first week of treatment, there is a higher risk of hypoglycemia, and blood sugar should be closely monitored, especially in elderly patients, those with poor nutritional status, individuals with irregular eating habits, or patients with reduced kidney or liver function. Additionally, the risk of hypoglycemia may increase in patients with certain endocrine disorders or those taking other medications, so it is essential to inform the attending physician or pharmacist. This medication can cause hypoglycemia, with symptoms including headaches, severe hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness; therefore, immediate action should be taken if these symptoms occur. Transient blurred vision may occur, as well as gastrointestinal symptoms such as nausea, vomiting, and abdominal pain. Serious side effects such as liver dysfunction or changes in blood cell counts can occur, so any unusual symptoms should be discussed with a healthcare professional. An allergic reaction can cause skin rashes, itching, and, in severe cases, breathing difficulties or shock, so if hives occur, immediate consultation with a physician is necessary. When taking this medication, dietary and exercise therapies should be maintained, and sugars should be consumed promptly to alleviate symptoms in cases of hypoglycemia. Furthermore, when receiving treatment at other hospitals or pharmacies, it is crucial to inform them about the use of this medication and the diabetic condition, and insulin therapy may be initiated during stressful situations or infections. Elderly patients should be cautious about dosage adjustments due to the potential for increased drug concentrations due to declining kidney function. In cases of overdose, severe hypoglycemia may occur, necessitating immediate emergency treatment, and appropriate care should be followed according to the physician’s directives. The safety and efficacy of this medication in children have not been established, so it should not be used in pediatric patients. When storing, keep it out of reach of children, and store it in its original container.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, reduced agility or lethargy, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, impaired liver function, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, impaired liver function, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius, at room temperature.
Light blue oblong tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Celix Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.